As of 2023-12-11, the Relative Valuation of Abbvie Inc (ABBV) is 148.44 USD. This relative valuation is based on P/E multiples. With the latest stock price at 149.28 USD, the upside of Abbvie Inc based on Relative Valuation is -0.6%.
The range of the Relative Valuation is 122.34 - 177.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.2x - 44.3x | 37.2x |
| Forward P/E multiples | 22.6x - 26.4x | 23.8x |
| Fair Price | 122.34 - 177.52 | 148.44 |
| Upside | -18.0% - 18.9% | -0.6% |
| Date | P/E |
| 2023-12-08 | 40.46 |
| 2023-12-07 | 40.11 |
| 2023-12-06 | 39.67 |
| 2023-12-05 | 39.18 |
| 2023-12-04 | 39.07 |
| 2023-12-01 | 38.87 |
| 2023-11-30 | 38.59 |
| 2023-11-29 | 37.54 |
| 2023-11-28 | 37.42 |
| 2023-11-27 | 37.70 |
| 2023-11-24 | 37.58 |
| 2023-11-22 | 37.53 |
| 2023-11-21 | 37.60 |
| 2023-11-20 | 37.49 |
| 2023-11-17 | 37.48 |
| 2023-11-16 | 37.48 |
| 2023-11-15 | 37.29 |
| 2023-11-14 | 37.42 |
| 2023-11-13 | 37.58 |
| 2023-11-10 | 37.56 |
| 2023-11-09 | 37.41 |
| 2023-11-08 | 38.50 |
| 2023-11-07 | 38.53 |
| 2023-11-06 | 38.27 |
| 2023-11-03 | 38.33 |
| 2023-11-02 | 38.83 |
| 2023-11-01 | 38.61 |
| 2023-10-31 | 38.27 |
| 2023-10-30 | 38.46 |
| 2023-10-27 | 37.66 |
| 2023-10-26 | 39.35 |
| 2023-10-25 | 39.37 |
| 2023-10-24 | 39.66 |
| 2023-10-23 | 39.23 |
| 2023-10-20 | 39.63 |
| 2023-10-19 | 39.44 |
| 2023-10-18 | 40.46 |
| 2023-10-17 | 40.43 |
| 2023-10-16 | 39.90 |
| 2023-10-13 | 40.10 |
| 2023-10-12 | 40.19 |
| 2023-10-11 | 40.48 |
| 2023-10-10 | 40.35 |
| 2023-10-09 | 40.41 |
| 2023-10-06 | 40.18 |
| 2023-10-05 | 39.96 |
| 2023-10-04 | 40.03 |
| 2023-10-03 | 39.96 |
| 2023-10-02 | 40.18 |
| 2023-09-29 | 40.40 |